本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Contineum Therapeutics, INC.

14.49
+0.66504.81%
成交量:58.20萬
成交額:837.10萬
市值:5.45億
市盈率:-8.42
高:14.60
開:13.97
低:13.74
收:13.82
52周最高:17.79
52周最低:8.60
股本:3,762.11萬
流通股本:2,782.33萬
量比:1.53
換手率:2.09%
股息:- -
股息率:- -
每股收益(TTM):-1.7201
每股收益(LYR):-2.1700
淨資產收益率:-28.01%
總資產收益率:-19.15%
市淨率:2.27
市盈率(LYR):-6.68

資料載入中...

2026/09/14

重要事件披露

Form 8-K - Current report
2026/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/28

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/17

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/14

重要事件披露

Form 8-K - Current report
2026/07/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/26

重要事件披露

Form 8-K - Current report
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors